首页 › 基金 › Enavate Sciences GP, LLC › SION
Enavate Sciences GP, LLC 对 SION 的持仓历史
SIONNA THERAPEUTICS INC · 医疗保健
Enavate Sciences GP, LLC 在 Q2 2026 的 13F 申报中披露持有 SION(SIONNA THERAPEUTICS INC)2,478,030 股,市值约 US$109.0M,约占其申报组合的 31.56%,在其申报持仓中市值排名第 1 位。 Enavate Sciences GP, LLC 最近 6 个申报季度中有 6 个季度披露了 SION 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Enavate Sciences GP, LLC 对 SION 的持仓演变
Enavate Sciences GP, LLC 于 Q1 2025 首次披露 SION 持仓:2,478,030 股(约 US$25.9M)。 该持仓在 Q2 2026 达到峰值 2,478,030 股,市值约 US$109.0M。 在 6 次申报中,Enavate Sciences GP, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 2,478,030 股、市值约 US$109.0M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 2.48M | $25.92M | 新进 |
| Q2 2025 | 2.48M | $42.99M | 持有 |
| Q3 2025 | 2.48M | $72.88M | 持有 |
| Q4 2025 | 2.48M | $101.95M | 持有 |
| Q1 2026 | 2.48M | $99.34M | 持有 |
| Q2 2026 | 2.48M | $109.01M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SION 与 13F 数据
SION(SIONNA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 86 只申报持有 SION,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SION 的基金
- RA CAPITAL MANAGEMENT, L.P. 9.91M 股 · $435.72M · Q2 2026
- TPG GP A, LLC 6.49M 股 · $285.71M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 3.00M 股 · $131.78M · Q2 2026
- ORBIMED ADVISORS LLC 2.56M 股 · $112.43M · Q2 2026
- PERCEPTIVE ADVISORS LLC 905.00K 股 · $39.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 680.92K 股 · $29.95M · Q2 2026
- Siren, L.L.C. 610.51K 股 · $26.86M · Q2 2026
- Casdin 资本 400.00K 股 · $17.60M · Q2 2026
- Kalehua Capital Management LLC 197.07K 股 · $8.67M · Q2 2026
- Sofinnova Investments, Inc. 144.43K 股 · $6.35M · Q2 2026
- GordonMD Global Investments LP 136.00K 股 · $5.98M · Q2 2026
- Sio Capital Management, LLC 127.81K 股 · $5.62M · Q2 2026
更多关于 Enavate Sciences GP, LLC
常见问题
How long has Enavate Sciences GP, LLC held SION?
Enavate Sciences GP, LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Enavate Sciences GP, LLC's current position in SION?
As of Q2 2026, Enavate Sciences GP, LLC holds 2.48M shares of SION (SIONNA THERAPEUTICS INC), valued at $109.01M, representing 31.56% of its reported portfolio and ranking #1.
Has Enavate Sciences GP, LLC been buying or selling SION?
In the latest 13F filing (Q2 2026), Enavate Sciences GP, LLC held unchanged its position in SION. The position peaked in Q2 2026 at 2.48M shares.
Which other funds hold SION?
Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, Atlas Venture Life Science Advisors, LLC, among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.